We have assembled two BAC vectors containing a single fragment spanning the entire CFTR locus and including the upstream and downstream regions. The two vectors differ in size of the upstream region, and were recovered in Escherichia coli, with intact BAC DNAs prepared for structural and functional analyses. Sequence analysis allowed precise mapping of the inserts. We show that the CFTR gene was wild type and is categorized as the most frequent haplotype in Caucasian populations, identified by the following polymorphisms: (GATT) 7 in intron 6a; (TG) 11 T 7 in intron 8; V470 at position 470. CFTR expression and activity were analyzed in model cells by RT-PCR, quantitative real-time PCR, western blotting, indirect immunofluorescence and electrophysiological methods, which show the presence of an active CFTR Cl À channel. Finally, and supporting the hypothesis that CFTR functions as a receptor for Pseudomonas aeruginosa, we show that CFTR-expressing cells internalized more bacteria than parental cells that do not express CFTR. Overall, these data demonstrate that the BAC vectors contain a functional CFTR fragment and have unique features, including derivation from a single fragment, availability of a detailed genomic map and the possibility to use standard extraction procedures for BAC DNA preparations.
Introduction
Cystic fibrosis (CF) is a recessive congenital disease that shows high incidence in Caucasian populations (ca. 1 in 2000) . CF is caused by mutations in the gene coding for CF transmembrane conductance regulator (CFTR; OMIM 602421), a Cl À channel that is expressed in the apical membrane of several epithelia. 1 CFTR is the main pathway for Cl À secretion; therefore, normal CFTR activity is necessary for the maintenance of the level of the airway surface liquid. Indeed, CFTR loss-of-function leads not only to reduced Cl À secretion, but also to increases in Na + and water absorption, probably because of a predominant activity of the epithelial Na + channel. In vitro models of well-differentiated CF epithelia have shown isotonic reduction of the surface liquid, and the consequent impaired movement of the overlying mucus; 2 the same has been seen in the lungs of CF patients, which are characterized by the presence of sticky mucus, leading to increased adherence of micro-organisms such as Pseudomonas aeruginosa. 3 Despite recent developments in the treatment of CF, there is no definitive cure for this disease and the life expectancy of the patient with CF is around 30-40 years. 4, 5 Since localization of the CFTR gene to the long arm of chromosome 7 in 1989, a huge effort has been put into the development of gene therapies for this life-threatening disease. To date, more than 30 clinical gene therapy trials have been performed worldwide, although with only very limited success. 6 The basic concept of gene therapy protocols is the cloning of the wild-type CFTR gene into canonical viral and non-viral vectors, and its application into the airways by topical instillation via a bronchoscope or nebulization. The target tissue is the pseudostratified epithelia lining the airways. It has been calculated that around 20% of the airway epithelial cells have to be gene corrected to result in normalized ion and water exchange across the respiratory epithelium. 7, 8 As effective therapy by such in vivo delivery of therapeutic DNA requires physiological levels of expression and long-term maintenance, it has been hypothesized that this can be achieved by using genomic fragments that contain all of the long-range controlling elements that will allow tissue-specific gene expression to a physiological level. 9 This is particularly important for CF, as CFTR is expressed at low levels in specialized epithelial cells of the gut, airways, pancreas, sweat gland ducts and reproductive tract. [10] [11] [12] [13] [14] Although CFTR expression was initially thought to be dictated by a 'housekeeping' promoter, it appears that regulation of CFTR expression involves interactions between a number of different regulatory factors and elements. Indeed, cell-specific expression is determined by regulatory elements that are upstream and downstream of the coding region, and are in various introns. 15 The human CFTR locus was isolated in a YAC vector of about 320 kb in size (YAC 37AB12) by Anand et al. in 1991, 16 and subsequently Manson et al. 17 showed that this vector complemented CF defects in cftrÀ/À mice. This study showed that YAC 37AB12 can drive physiological levels of expression in many of the cells, in which CFTR is normally expressed, and that the human protein effectively restored Cl À secretory responses in null mice, thus suggesting that the YAC insert contains all of the sequence information required for correct CFTR expression. 17 Since then, no further improvements or characterizations of this fragment have been carried out, probably due to the difficulties of working with YAC vectors. We believe that this vector constitutes a unique opportunity to map all of the regulatory information underlying CFTR expression that spans about 60 kb upstream and 50 kb downstream.
Of note, the mechanisms that are involved in specific tissue and temporal CFTR expression have yet to be fully elucidated. Several studies aimed at identifying the basic promoter region and the accessory elements of the human and mouse CFTR genes have often given rise to inconsistent results. Deletion analyses of a 5 0 upstream fragment of about 4 kb have failed to reveal any obvious TATA elements, although they did identify sequences between À357 and À33 bp that can drive transcription of a reporter gene. 18 Moreover, the presence of a negative element (À345 to À277) has been reported, which completely suppressed expression when used in a transient assay system. 18 Some of the regulatory elements are conserved in the mouse, rat and human CFTR promoters, but none of these can account for the tissuespecific pattern of CFTR expression. 19, 20 Furthermore, 19 kb of genomic DNA upstream of the CFTR gene failed to drive reporter-gene expression in transgenic mice, which suggests that important regulatory elements lie outside of this region. The suggestion that the CFTR control elements might be far away from the 5 0 end of the gene comes from the mapping of two DNaseI hypersensitive sites, which are often associated with regulatory elements, to À20.5 and À79.5 kb from the start site. 21 A cluster of five DNaseI hypersensitive sites were also identified in the region 3 0 to the CFTR gene, at +5.4, +6.8, +7.0, +7.4 and +15.6 kb; the appearance of these DNaseI hypersensitive sites did not correlate fully with CFTR expression, although they might contain elements that contribute to the tissue specificity of CFTR expression. Moreover 11 DHS clusters have been identified within introns 1, 2, 3, 10, 16, 17a, 18, 20 and 21, some of which are restricted to specific cell types, although only one, the intron 1 DHS, has been shown to completely correlate with cell-type-specific CFTR expression. 22 Very recently, it was reported that the +6.8 DHS functions as an insulator and mediates interactions with the CFTR promoter, suggesting that the CFTR locus exists as a loop that is characteristic of an active chromatin hub. 23 The clinical history of CF patients is characterized by bacterial infections of the lung that become infected in an age-dependent manner: by Staphylococcus aureus and Haemophilus influenzae in early childhood, and Pseudomonas aeruginosa in late adolescence. Other pathogens, such as those from the Burkholderia cepacia complex, can cause rapid clinical decline in a subset of usually older patients. Among the different hypotheses that have been formulated to explain how the loss of CFTR activity can contribute to lung disease in patients with CF, the binding of bacteria to wild-type CFTR of epithelial cells has been suggested to initiate a self-limiting inflammatory response that contributes to eliminate bacteria (reviewed by Campodonico et al.
24
). An additional component of the wild-type CFTR-dependent response to P. aeruginosa is endocytosis of bacteria by the epithelial cells, and the subsequent clearance of infected epithelial cells by desquamation. 25, 26 In this study, and for the first time to our knowledge, we report on the circularization and transfer into bacterial cells of YAC 37AB12, which contains an insert spanning the intact human CFTR locus plus additional 5 0 and 3 0 DNA. We have produced two versions of this circular BAC that differ in the 5 0 upstream DNA by about 25 kb. The CFTR insert was precisely mapped and the allele variant was characterized by sequence analysis. A number of functional assays in model cell systems confirm the activity of the CFTR gene cloned into this BAC.
Results

From YAC-CFTR to BAC-CFTR
YAC37AB12 containing the intact CFTR locus 16 was converted into a circular BAC by using the retrofitting plasmid pNK-G418 (Figure 1a) . 27 Following recombination, pNK-G418 replaces the YAC arms, which leads to the formation of a circularized YAC, the replication of which depends on the activity of ARS-like sequences in the human insert. Circularized YACs were identified by electrophoretic karyotyping, which discriminates between linear and circular yeast chromosomes of the same size as the latter remain entrapped in the wells of the agarose gels. 28 In this way, the absence of a DNA band at the position occupied by the linear YAC was attributed to the presence of a circularized YAC. As shown in Figure 2a , both the ethidium bromide-stained gels and the southern hybridizations of a CFTR probe revealed linear YAC in the parental 37AB12 strain, but not in clone 5A. That this clone contained the circularized YAC was further demonstrated by SalI restriction digestion, which released the CFTR fragment to migrate into gels according to its size (Figure 2b ).
To insert a selectable marker for mammalian cells into the circularized YAC, we performed a second DNAreplacement experiment. The region between À50 and À25 kb from the CFTR start codon was exchanged with a fragment containing markers for the selection of mammalian cells (zeocin) and for yeast cells (phleomicin) (Figure 1b ). This substitution would cause a size reduction in the circular YAC of 25 kb, leading to a circular molecule smaller than 300 kb, which is more suitable for replication into bacterial cells. To the best of our knowledge, the region to be eliminated does not contain features correlated with CFTR expression, and it is sufficiently far from the DHS at À20.9 kb that has been associated with tissue-specific expression of CFTR.
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The targeting fragment that contained the markers was flanked by two short regions, Up2 and Up1, to promote recombination with circular YAC (Figure 1b ). This fragment was transformed into yeast clone 5A, and PhleoR clones were isolated and analyzed by PCR. Yeast clone D12 showed the markers zeocin and phleomicin as well as the entire targeted fragment (Up1-Up2); in addition, PCR for the left junction between the targeted fragment and vector (Up1-phleo) gave the expected DNA band, which showed that integration had occurred at the expected site ( Figure 2c ). Furthermore, pulsed-field gel electrophoresis (PFGE) analysis revealed that the SalI CFTR fragment of yeast clone D12 was smaller than that of the parental 5A ( Figure 2b) . Next, the circular YAC/BACs in the yeast clones D12 (cCFTRD12) and 5A (cCFTR5A) were recovered into E. coli EC100 cells. First, all of the bacterial clones obtained were analyzed for the presence of the CFTR gene by colony-PCR for exon 10, and the expected band was seen in one of the three cCFTR5A clones and in 7 out of 12 of the cCFTRD12 (Supplementary Figure 2) . The cCFTR5A and one cCFTRD12 randomly selected from the CFTR-positive clones were analyzed in more detail. Small-scale BAC DNA was prepared from each of two single cell-derived clones, and PCRs were carried out for the CFTR exons 1, 2, 5, 7, 10, 13 and 20, and for a portion of the BAC module. The results of this analysis demonstrated that all of the BAC DNAs amplified the expected fragments. Moreover, the presence of the same fragment in the two sub-clones strongly suggested that the molecules did not suffer gross rearrangements in E. coli (Figure 3a) .
Macro-restriction with SalI gave the expected fragment in both the cCFTR5A BAC and the cCFTRD12 BAC (Figure 3b ). In addition, restriction with frequent-cutting enzymes showed similar restriction profiles, which were not identical due to the upstream deletion in cCFTRD12 (Supplementary Figure 3) . Sequencing was performed in two steps: first, the left and right ends of the insert in cCFTR5A and cCFTRD12 were determined by walking the CFTR locus inwards from the original EcoRI cloning sites ( Figure 4) ; second, all of the exons and the intron/ exon junctions, and the proximal 5 0 -flanking region were sequenced. Sequence analyses demonstrated that cCFTR5A contained an insert running from À49 923 bp upstream of the CFTR start codon (position 42 245 379 of the reference contig. NT_00793.14) to +58 214 bp downstream of the stop codon (position 42 542 218; NT_ 00793.14) (Supplementary Figure 1) . The two vectors cCFTR5A and cCFTRD12 showed the same 5 0 and 3 0 ends, confirming that the pruning procedure occurred as expected; additionally, we found that the 5 0 upstream DNA removed in the cCFTRD12 vector corresponded to the region spanning from À25 696 to À49 788 bp (position 42 277 897-42 253 805 of the reference contig. NT_00793.14). Sequence analysis of all of the introns, intron/exon junctions and the proximal 5 0 -flanking region of the CFTR locus showed them to be wild type, and the polymorphisms studied were as follows: the repeats in intron 6a were (GATT) 7 ; the repeats in intron 8 were (TG) 11 T 7 ; the polymorphic site at aminoacid 470 was V470 (Figure 4) . Overall, the BAC cCFTR5A, and its derivative cCFTRD12, contain the most common wt-CFTR haplotype in the Caucasian population.
Functional analysis of CFTR in mammalian cells
The CFTR channel mediates the epithelial transport of Cl À through the apical membrane. In addition, it has been proposed to be involved, either directly or indirectly, in other cellular activities, including cell-bacteria interactions (reviewed in Quinton et al. 14 and Campodonico et al. 24 ). Functional analysis of the
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Sal I H IS 3 K a n M X C E N 6 cCFTRΔ12 (~275 kb) CFTR expression from the human locus in BAC vectors C Auriche et al human CFTR locus cloned into BAC vectors demands a cellular model that has the endogenous CFTR locus distinguishable from the exogenous one. The best conditions would be those where endogenous CFTR is not expressed, whereas the expression and Cl À channel activity of exogenous CFTR can be detected easily. In cells of human origin, analysis of exogenous CFTR would be disturbed by the presence of the endogenous wild-type gene, making it difficult to distinguish the two loci, and almost impossible to attribute the Cl À channel activity to one of them. Even the use of human cells with mutated CFTR alleles would not solve the problem, because the most common mutations (including the frequent dF508) might have residual CFTR activity. 29 FRT cells do not express endogenous CFTR, as demonstrated in previous studies on the wild-type and mutated proteins; therefore, this cell line represents an excellent recipient model for our BAC vector. 30 To transfer CFTR-BAC into FRT cells, large-scale DNA preparations from the cCFTR5A and cCFTRD12 were first analyzed for DNA integrity by restriction digestion and long-range PCR, the latter being particularly sensitive to singlestrand and double-strand breaks that cause breakdown of the polymerization complex. SalI digestion of BAC DNAs revealed the expected band without any detectable smear that would be due to DNA degradation ( Figure 3b ); long-range PCR for the regions spanning exons 4-9 (17.9 kb) and 17-19 (12 kb) gave the expected bands with both cCFTR5A and cCFTRD12 DNAs, confirming that the DNAs were of good quality (Supplementary Figure 4) . Since cCFTR5A does not contain a selectable marker for mammalian cells, it was used in co-transfection with pcDNAzeo. Two days after transfection, zeocin selection was applied and the cells were cultivated for an additional 10-14 days until the appearance of zeo-resistant clones. Two clones from the 
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C Auriche et al transfection with cCFTR5A, and 12 clones from that with cCFTRD12 were isolated. The two FRT/cCFTR5A clones died during subsequent passages, suggesting that the co-transfection procedure did not work. All of the FRT/cCFTRD12 clones, (named FRTcl1-12) survived and showed the presence of cCFTRD12, as detected by PCR for CFTR exon 10 (data not shown).
To assess the activity of the CFTR locus, we analyzed CFTR mRNA and the CFTR protein, as well as the transepithelial Cl À current. First, real-time quantitative PCR clearly showed the presence of CFTR mRNA in half of the clones analyzed, although at different levels ( Figure 5a ). Next, CFTR activity in the six positive clones and in one negative clone (FRTcl1) was evaluated by measuring Cl À secretion on FRT epithelia. To this end, we seeded the cells at high density on permeable supports and allowed them to form a high-resistance epithelium. For measurements of CFTR-mediated transepithelial Cl À currents, we mounted the supports in a Ussing chamber that was connected to a voltage-clamp amplifier. The activity of CFTR was stimulated by increasing intracellular cAMP concentrations with forskolin, an activator of adenylyl cyclase. Next, the potentiator genistein was added to further increase the CFTR current in case it was not fully activated by forskolin. The amplitudes of the CFTR currents were obtained from the total current blocked by the specific CFTR inhibitor CFTR inh -172. 31 The best clone, FRTcl7, responded to the cAMP agonist with a short-circuit current increase of ca. 18 mA cm À2 ( Figure 6 ). The clones FRTcl2, FRTcl4, FRTcl5 and FRTcl6 were also active, although less so than FRTcl7. The remaining two clones (FRTcl1 and FRTcl3) did not show any detectable activity. As expected, parental FRT cells were negative in this test, whereas human T84 cells, which are known to express high levels of wt-CFTR and which were used here for comparison, showed the highest activity ( Figure 6 ).
Both the real-time PCR and the CFTR currents suggested that the FRTcl7 clones synthesize the full-size wt-CFTR protein. To confirm this, we analyzed the full-length mRNA by PCR, and the protein by western blotting. Overlapping RT-PCRs clearly showed the presence of the full-length human CFTR mRNA in the FRTcl7 clone, whereas no amplification bands were detected in the parental FRT cells (Figure 5c ). Western blotting revealed wt-CFTR in control T84 cells and in the FRTcl7 clone. In these cell lines, the 170-kDa band, corresponding to fully glycosylated CFTR (band C) and a very faint 150-kDa band, corresponding to the coreglycosylated CFTR (band B) could be detected, although CFTR expression from the human locus in BAC vectors C Auriche et al the amount of the CFTR protein in the FRTcl7 clone was less than in the control (Figure 5b) .
The different activities of the human CFTR gene in these FRT clones might be due to differences in the copy numbers of the integrated loci and/or to epigenetic effects arising from the nearby chromatin. To address this point, we determined the copy number of the two most active clones, FRTcl2 and FRTcl7. First, we selected primers which amplified a region of 500 bp flanking exon 4 in both the human and the rat CFTR loci, as demonstrated by control PCRs (data not shown). The CFTR copy number was determined in the FRTcl2 and To determine whether the two CFTR loci in the FRTcl7 clone were integrated into the same genomic site, we performed FISH analysis using cCFTRD12 DNA as a probe. This analysis confirmed the absence of the endogenous CFTR in FRT cells, as shown by the absence of hybridization signals in FRT parental cells (data not shown), and instead revealed one signal in the FRTcl7 clone, in an unidentified medium-sized chromosome, suggesting that the two CFTR copies were integrated into one chromosomal site (Figure 7 ). CFTR expression from the human locus in BAC vectors C Auriche et al
Finally, we used confocal microscopy to investigate the presence of the CFTR protein in the FRTcl7 clone, which showed the highest CFTR mRNA level and Cl À current. First, to look for the correct formation of tight junctions, parental cells and the FRTcl7 clone were grown on filters, stained with occludin (Figures 8j-l and i-k, respectively) . Subsequently, the epithelium formed by the parental control (FRT) cells and by the FRTcl7 clones were stained with an anti-CFTR antibody. With this analysis, the CFTR protein was not seen in the parental cells (Figures 8e-h) , whereas it was seen in the FRTc17 clones expressing the transgene (Figures 8a-d) .
CFTR-bacteria interaction
It has been proposed that CFTR functions as an internalizing receptor for P. aeruginosa, by binding of the outer core LPS of P. aeruginosa to amino acids 108-117 of CFTR; 26 this suggests that CFTR has a direct and/or an indirect role in this process. Thus, we hypothesized that CFTR expression and its correct trafficking to the apical CFTR expression from the human locus in BAC vectors C Auriche et al membrane in FRT cells would change the rate of P. aeruginosa internalization. To test this hypothesis, we performed bacterial invasion assays using a clinical isolate of P. aeruginosa and cells grown on a permeable support until a high-resistance epithelium was formed (see Materials and Methods). The results of three independent experiments showed a significant increase in the intracellular bacteria in the FRTcl7 clone, with respect to parental cells ( Figure 9) . Similarly, the fraction of internalized bacteria was higher in human respiratory cells that endogenously express wt-CFTR (16HBE cells) with respect to CFBE cells that express F508del-CFTR (data not shown). Overall, these results suggest that when infected with P. aeruginosa, cells expressing wt-CFTR can internalize significantly more bacteria than cells that do not express a functional CFTR.
Discussion
In this study, and for the first time to our knowledge, we report the functional characterization of the human CFTR gene cloned in a BAC vector along with its upstream and downstream regions. Starting from YAC-CFTR that contains the entire CFTR locus, we obtained two BACs, cCFTR5A (300 kb) and cCFTRD12 (275 kb), which were both recovered in bacterial cells by electroporation of intact yeast DNA. These two BACs differed in the 5 0 region of the CFTR locus: the upstream region of cCFTR5A extends for about 50 kb, whereas cCFTRD12 has 25 kb upstream of the start codon; moreover, cCFTRD12 contains a zeocin-selectable marker inserted at À25 kb. These BACs were extracted from the bacterial cells, and analyzed by PCR and sequencing. The results of these analyses allowed the precise mapping of the inserts with respect to the data in gene bank, along with sequence determination of all of the exons and intron/ exon junctions and identification of polymorphic sites. This also shows that the CFTR allele cloned into the BAC cCFTR5A and cCFTRD12 represents the most frequent wild-type allele in the Caucasian population.
It has been reported that Lipofectamine 2000 allows transfection of BACs up to 150 kb in size into mammalian cells. 32 Indeed, Kotzamanis et al. 33 reported that CFTR containing BAC vectors of 258.4 and 268.1 kb were not transferred intact into mouse cells by Lipofectamine 2000. We assume that a critical step in this procedure is the preparation of good quality DNAs, which should be intact and sufficiently free of double-strand and singlestrand breaks. DNA isolation in agarose plugs has been proposed as a method to obtain intact DNA of very large molecules from bacteria, 34, 35 although the procedure is very time consuming and it requires multiple steps of DNA purification by PFGE to get rid of the bacterial chromosomal DNA. In this way, we have optimized an in-house extraction method that yielded BAC DNA of good quality, as certified by long-range PCRs and allowed Lipofectamine-mediated transfer of the cCFT RD12 BACs into mammalian cells. However, we were not able to recover FRT clones containing the larger BAC (cCFTR5A). As the experimental conditions used with the two BACs were different because of the absence of a selectable marker in the 325-kb BAC, other factors rather than simply the size appear to be the cause of this.
To allow functional analysis of the CFTR locus cloned into the BACs, we chose FRT cells as the host cells for a number of reasons: they have been extensively used to analyze CFTR activity of ectopic genes; they are easy to cultivate even under conditions that induce cell polarization and tight-junction formation; the sequence of the endogenous CFTR locus is sufficiently different from that of the human; and they do not express endogenous CFTR, which is an essential feature for functional analysis of exogenous CFTR. 30 As already mentioned above, we obtained stable clones only from transfection of FRT cells with the BAC cCFTRD12, which produced 12 clones. Six of these 12 clones showed CFTR mRNA, as revealed by real-time PCR and five of them showed CFTR-mediated transepithelial Cl À currents. The functional analyses revealed some differences among the CFTR-expressing clones, not only in the amounts of CFTR transcript present, but also in their CFTR-dependent Cl À secretion. A comparative analysis of the data revealed that the clones that showed the highest CFTR mRNA levels also showed the highest cAMP-dependent CFTR Cl À transport; among these, the clone with the highest mRNA levels (FRTcl7) showed the highest shortcircuit current increase after stimulation with forskolin. It is worth noting that the Cl À channel activity recorded in the FRTcl7 clone resulted from an mRNA level that was about three orders of magnitude lower than that in the positive control (T84 cells), and the levels of the wt-CFTR protein were about 5-fold less than those in the T84 cells. It has been shown that when driven by an heterologous promoter, CFTR expression needs to be significantly higher than endogenously expressed CFTR to restore the CFTR Cl À transport. 36 Here, we have shown that in FRT cells, the human CFTR gene driven by its own promoter is functionally active, although low levels of CFTR transcripts and protein were detected. Moreover, the amplitude of the CFTR transepithelial current recorded with the BAC-transfected FRT clones (in the order of 5-20 mA cm
À2
) is comparable to that recorded for primary epithelia of human bronchial cells, 37 although much lower than that is recorded for plasmid-transfected FRT cells under the same CFTR expression from the human locus in BAC vectors C Auriche et al experimental conditions (150-300 mA cm
, Zegarra Moran et al.
30
). These characteristics substantiate the importance for this gene therapy of including the CFTR promoter, so as to obtain 'physiological' levels of CFTR and the appropriate transepithelial Cl À secretion. Although FRT cells do not express endogenous CFTR, expression of the human CFTR gene was detected. This might be due to: (i) the absence of cell-type specific and/or species-specific regulatory elements; and (ii) the sequence diversity between the rat and human genomes, which might impair the activity of the endogenous regulators toward the human gene. At this stage, we have no evidence to indicate, which hypothesis might be correct indicating the need for further analyses to fully define the factors governing cell-specific and species-specific expression of the CFTR gene.
Although CF is a multisystem disease, the major problem for patients with CF is seen as bacterial infections of the airways. Among the opportunistic pathogens that can be acquired by CF patients, P. aeruginosa is the most problematic and is the bacterial infection that is most often linked to a decline in lung function. Indeed, the molecular mechanisms that mediate cell-bacteria interactions and intracellular bacteria survival in CF versus non-CF cells are still poorly understood. At present, one of the main points of discussion in the CF field is how CFTR mutations result in chronic lung infection and deteriorating lung function. Among the various working hypothesis, Pier et al. 25 proposed that by functioning as a receptor for P. aeruginosa (CFTR-receptor hypothesis), CFTR mediates bacteria internalization and contributes to initiation of a self-limiting immune response that ultimately leads to bacteria elimination (reviewed in Campodonico et al. 24 ). Such a pathway would be absent in the CF airway, and the appropriate immune response fails to resolve the bacteria infection leading to chronic infection. The analysis of the mechanisms responsible for bacterial killing have opened a debate on the possible role of intracellular CFTR activity in epithelial cells and in cells of innate immunity. A lot of contrasting data have been published recently on the role of CFTR in the acidification of intracellular organelles, an important step toward removal of bacteria from the airways. 38 In this scenario, we have investigated whether the quasi-isogenic FRT cells and FRTcl7 clone show any differences in their ability to take up bacteria. Our results show that cells expressing CFTR (the FRTcl7 clone) can internalize a significantly greater number of bacteria with respect to the parental cells that do not express CFTR. Although we do not know the precise molecular mechanisms involved in this process, it appears that CFTR expression has an important role. It should be considered that CFTR binding is not a common action of all P. aeruginosa clinical isolates, and that late isolates lose this ability. This would thus suggest that the P. aeruginosa-CFTR interaction is particularly relevant in the early stages of infection, whereas chronic infection would rely on other properties of the bacterium and host cells. 39 A comprehensive knowledge of the biology of CF has so far been hampered by the absence of fully functional cellular and in vivo models for a comparative analysis of wild-type versus mutated CFTR activity. Very often, CF studies have made use of: (1) CF and non-CF cells isolated from different donors; and/or (2) CF-corrected and CFTR-corrected cells. In the former approach, CF and non-CF cells have different genetic backgrounds, introducing unknown variations into the results; this is even more problematic when immortalized cell lines are used, which during immortalization may undergo unpredictable, and very often undetected, karyotype changes and thus gene copy number alterations. In the latter approach, the same cells have been used, with one set 'corrected' using a CFTR-expressing cassette. Here, the problem is represented by the complementing gene, which usually consists of a cDNA expression cassette driven by strong heterologous and often viral promoters, which have been found to be susceptible to transcriptional silencing 40 and do not ensure physiological expression of the transgene. As the experimental evidence suggests that the provision of a natural genomic context that includes the promoter and other control elements can guarantee sustained and specific expression over long periods, 41 we propose the use of the model cells we have developed in the present study for functional analyses of human CFTR. In addition, the BAC vectors that we have constructed can be further engineered to introduce cognate mutations anywhere along the insert. For example, mutated versions of BAC can be produced for functional studies of specific CFTR mutations; also the haplotypes, which are believed to produce reduced CFTR mRNA levels, can be evaluated functionally in this way. This is facilitated by the detailed mapping of the insert that we have carried out, with the possibility of modifying BAC either in yeast, using the same rationale we describe here, or in E. coli, using a RecE/T system. 42 We have successfully used RecE/ T-mediated recombination to engineer the cCFTRD12 vector (Ascenzioni F, unpublished results). Another advantage of the CFTR-containing BAC that we have assembled arises from the possibility of using standard DNA extraction procedures, which only require limited laboratory training to avoid DNA shearing during the extraction. Having demonstrated the functional activity of the CFTR locus contained in cCFTRD12, this BAC and its parental vector, cCFTR5A, should guarantee maximal and tissue-specific CFTR expression in human cells, and would therefore be the best starting material to dissect out the regulatory regions of CFTR and to assemble the genomic context vectors for gene therapy applications.
Recently, similar CFTR-containing constructs have been published that differ in the size of the insert, and most important, in the assembly procedure. Kotzamanis et al. 33 produced a CFTR-BAC of about 250 kb using a multistep recombination procedure that they carried out in E. coli, which used three BACs overlapping the CFTR locus. Thus the resulting molecules may not be representative of an authentic human CFTR locus. Although no data relating to the activity of the CFTR Cl À channel was provided, because of the presence of endogenous CFTR in their system, these authors demonstrated CFTR expression at the mRNA level in mouse cells. Clones containing integrated copies of BAC showed higher levels of human CFTR expression, probably due to copynumber variations, whereas episomal copies of their BAC, which were based on the oriP/EBNA1 element, showed lower levels of transcription with respect to the endogenous gene. 33 CFTR expression from the human locus in BAC vectors C Auriche et al
The CFTR-BAC vectors that we have described in this study are the best characterized genomic vectors that have been published to date, from both the structural and functional points of view. Thus, in addition to the vector assembled by Kotzamanis et al., 33 these offer a wide range of genomic constructs for CF research studies.
Materials and methods
Cells and plasmids Mammalian cells. Fisher rat thyroid (FRT; ATCC N. CRL-1468) cells were cultured in Coon's modified F12 containing 5% fetal bovine serum, 2 mM L-glutamine, 100 U ml À1 penicillin and 100 mg ml À1 streptomycin. Artificial epithelia were obtained by seeding FRT cells at high density (500 000 cells cm À2 ) into Snapwell permeable supports (Corning Life Sciences, Corning, NY, USA), with the apical and basolateral media replaced every 24 h. Experiments were carried out 7-10 days after seeding of the cells, when the epithelia had a transepithelial resistance in the range of 2-3 kO cm 2 , as measured using chopstick electrodes.
Yeast strain. YAC 37AB12 16 was obtained from the YAC bank at H.S. Raffaele Scientific Institute (Milan, Italy); pNK-G418 was kindly provided by Dr R Nagaraja; 27 pcDNAzeo was from Invitrogen.
CFTR-YAC circularization and insertion of markers
YAC37AB12 containing the intact CFTR locus was circularized using linearized pNK-G418, as previously described. 27 Yeast transformants were selected in agar plates supplemented with 250 mg l À1 G418, and incubated at 30 1C until primary isolates could be picked. Single-cell colonies were replica plated on complete medium lacking either uracil or tryptophan. Yeast clones with the trp À , ura À and G418 R phenotype were collected. The targeting fragments that contained the markers phleomicin (for yeast) and zeocin (for mammalian cells) were produced by multiple rounds of PCR; the template for the gene conferring resistance to phleomicin was pUG66; 43 the template for the zeocin gene was pcDNAzeo (Invitrogen, Carlsbad, CA, USA). Details of the constructs and the procedures are described in the Supplementary Information.
Pulsed-field gel electrophoresis of intact yeast DNA
Total yeast DNA was prepared in agarose plugs by standard methods. 44 The agarose plugs were incubated overnight at 37 1C with SalI, using the manufacturerrecommended buffer (Roche Applied Science, Mannheim, Germany); 60 U of the enzyme was used per 100 ml plug. Undigested and digested plugs were separated by pulsed-field electrophoresis in a CHEF Mapper apparatus (CHEF-Mapper DRII, Bio-Rad, Bio-Rad Segrate, Italy) under the conditions that separate Saccharomyces cerevisiae chromosomes. The gels were dehydrated, and southern hybridization was carried out with [ 32 ]P-dCTP-labeled pCMV-CFTR4.6. 45 
BAC DNA preparation
Small-scale BAC DNA was prepared according to standard procedures, from 5 ml culture grown overnight at 37 1C. Large-scale DNA preparations were carried out with 500 ml cultures in LB medium with the appropriate antibiotic. These were grown overnight at 37 1C under vigorous shaking, following the protocol described by Sambrook and Russell (2001) . 44 This was carried out with the following precautions: the bacterial cell lysates were always handled with wide-bore pipettes and tips (yellow and blue tips cut for a 2-3 mm diameter hole); mixing was always by gentle swirling; and DNA pellets were dissolved in ddH 2 O overnight at 4 1C. The appropriate quality of the BAC preparations was assessed using two assays: (1) conventional gel electrophoresis, which showed high molecular weight DNA entrapped in the wells and no bands smeared due to DNA degradation; and (2) PFGE of linearized BAC and/or long-range PCR analysis. DNA was kept at 4 1C and used to transfect mammalian cells within a few days.
PCR and sequencing
PCR was performed with 100 ng DNA (from small-scale preparations) and primers specific for the CFTR exons. The primers for exons 1, 2, 5, 7, 10 and 13 were those reported in Zielensky et al. YAC/BAC sequencing, and sequencing of all of the CFTR exons, adjacent intron/exon boundaries and the 1028 bp upstream of the 5 0 -UTR were performed by cycle sequencing (Applied Biosystems, Warrington, UK), as described previously. 47 The (TG) m T n tract was also analyzed by cycle sequencing, as previously described. 48 
Transfer of circular YAC/BACs into Escherichia coli cells
Agarose plugs containing intact yeast DNA were washed 3 times with ddH 2 O at room temperature, melted at 68 1C for 15 min, cooled to 45 1C for 10 min and finally incubated with 1.5 U agarase at 45 1C for 1 h. Agarase digestion was controlled by chilling the DNA mixture on ice for 10 min, the reaction was stopped when no solid agar particles should be visible. The melted plugs were diluted 1:1 with ddH 2 O, and 1 ml aliquots were used to electroporate 40 ml of E. coli EC100 competent cells (Epicentre Biotechnologies, Madison, Wisconsin, USA). We used a Bio-Rad Gene Pulser with the following parameters: 2.5 kV, 200 O and 25 mF. At least three electroporations were carried out for each DNA CFTR expression from the human locus in BAC vectors C Auriche et al preparation. Colonies were selected on LB plates with 12.5 mg ml À1 chloramphenicol.
FRT cell transfection
The day before transfection, 1 Â 10 6 FRT cells were seeded in 60-mm Petri dishes. Transfection was carried out with about 15 mg good quality BAC DNA and Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA), following the manufacturer's instructions. For co-transfections, we used a mixture of BAC DNA and pcDNAzeo at a ratio of 10 to 1. Zeocin was added to the medium at 800 mg ml
À1
, 48 h post-transfection; the selected clones were maintained in 600 mg ml À1 zeocin.
RNA isolation, RT-PCR and real-time quantitative PCR
Total RNA was isolated from FRT cells using TRIzol (TRIzol Reagent, Life technology, Invitrogen), and subsequently treated with DNase and purified using an RNeasy mini kit (Qiagen, Hilden, Germany), according to the manufacturer's instructions. Full-length CFTR mRNA was analyzed by RT-PCR, with the RT step using 1 mg total RNA in an overall reaction volume of 20 ml, with the iScript cDNA Synthesis kit (Bio-Rad, Segrate, Italy). The PCR step used 0.40 pmol ml À1 of the overlapping primers, as described in Supplementary Table 1 . The PCR mix was in a final volume of 15 ml, and included: 2.5 ml RT mix, 0.5 U Taq polymerase YieldAce (Stratagene, Santa Clara, CA, USA), 175 mM of each dNTP and 1 Â YieldAce polymerase buffer. The PCR step was conducted in a PTC100 thermocycler (MJ Research, Walthan, MA, USA) with a pre-activating step of 2 min at 92 1C, followed by 35 cycles of 45 s at 94 1C, 1.5 min at 60 1C and 2.5 min at 72 1C, followed by an extension step of 7 min at 72 1C. The correct sizes of the amplicons were verified by size-interpolating software, as compared with molecular weight markers.
Real time PCR was carried out with cDNA that was obtained using the Reverse Transcription System kit (Promega Corporation, WI, USA) and SYBR Green PCR Master Mix (Applied Biosystems), according to the supplier specifications. The primers were as follows: for CFTR, rtCF- and rtbeta-ActR1 5 0 -TGGTGATGACCTGGCCGT-3 0 . CFTR copy numbers were determined by real-time PCR, on DNA using primers matching both human and rat CFTR. Standard curves of the two amplicons (CFTR, and rat actin as internal control) confirmed that the two regions amplified with the same efficiency. The primers were: CFTR, CF4-F1 5 0 -CTCCCACTGTTGCTATAACAA ATCCC-3 0 and CF4-R1 5 0 -AGCATTTATCCCTTACTTG TACCAGC-3 0 ; actin, RatACT-F 5 0 -GCTGCAGGATCGT GAGGAAC-3 0 and RatACT-R 5 0 -CGGAAAGTTAAGCT TTGCCAGT-3 0 .
Western blotting
The CFTR protein was detected by western blotting, as reported by Farinha et al. (2004) , 49 using the mouse 596 monoclonal antibody (Cystic Fibrosis Foundation Therapeutics Inc, Bethesda, MD, USA), which detects the NBD2 domain; 50 the secondary antibody was an anti-mouse IgG (NA 931 V, GE Healthcare/Amersham, Freiburg, Germany). Detection was by ECL, using western blotting detection reagent RPN 2106 Amersham GE Healthcare. Blots were reprobed with a mouse anti-a-tubulin (B-7) monoclonal antibody (sc-5286, Santa Cruz Biotechnology Inc, Santa Cruz, CA, USA), as loading controls.
FISH and immunofluorescence
FISH was performed according to Auriche et al. (2001) . 51 The probe was cCFTR5A fragmented by Sau3A digestion and labeled with a random-primed DNA-labeling kit, using digoxigenin-11-dUTP (Roche Applied Science, Mannheim, Germany). Hybridization was detected with an anti-digoxigenin antibody conjugated with fluorescein.
Indirect immunofluorescence was carried out as previously described, 52 using cells seeded at high density in Transwells and grown until artificial epithelia were formed (5-7 days after plating). The primary antibody was an anti-CFTR antibody (H-182, Santa Cruz Biotechnology Inc), the secondary was a fluorescein isothiocyanate-conjugated anti-rabbit antibody (1:1000, Molecular Probes, Eugene, OR, USA). The omission of the primary antibody resulted in the absence of staining. Occludin immunodetection was carried out with a fluorescein isothiocyanate-conjugated mouse anti-occludin antibody (Zymed Laboratories Inc, San Francisco, CA, USA). Filters were excised and placed on a glass slide with the cells side up, and overlaid with a drop of Fluorescent Mounting Medium (Dako, Milan, Italy), followed by a coverslip. The cells were analyzed using a Nikon TE2000 microscope coupled to a Radiance 2100 confocal duallaser scanning microscopy system (Bio-Rad, Segrate, Italy). The specimens were viewed through a Â 60 oilimmersion objective lens. Digital images were processed using the Laser Sharp 2000 program (Bio-Rad Segrate, Italy).
Bacteria invasion assay
FRT cells were seeded and grown on permeable supports, as described above. The non-mucoid P. aeruginosa clinical isolate Pa 696 was grown overnight in tryptic soy medium. Bacterial cells from 1 ml culture were collected by centrifugation, washed twice with normal saline solution (0.9% NaCl) and diluted, usually 1/10, in serum-free tissue-culture medium. The bacterial cell suspensions were used to infect the FRT cells at a multiplicity of infection of 20-30:1, bacteria to cell. The filters were centrifuged at 500 Â g for 10 min, and then incubated at 37 1C in 5% CO 2 for 1 h, to allow bacterial entry. The cells were then washed three times with PBS and incubated in medium containing ceftazidime and amikacin (1 mg ml À1 each) for 60 min, to kill the extracellular bacteria. To release the intracellular bacteria, the cells were lysed with 1% Triton X-100 in PBS and the bacteria were counted by plating serial dilutions of the lysates on Pseudomonas isolation agar plates. Three independent infection assays were performed, and each experiment consisted of two filters for each cell type. The fractions of internalized bacteria were determined with respect to the CFU used to infect the cells.
Short-circuit current recordings
For Ussing chamber experiments, FRT cells were seeded into Snapwell permeable supports as described above. Experiments were carried out 8-10 days after seeding, CFTR expression from the human locus in BAC vectors C Auriche et al when the epithelia had a transepithelial resistance in the range of 2-3 kO cm 2 , as measured using chopstick electrodes. Snapwell inserts were mounted into a Ussing-like vertical diffusion chamber. The basolateral solution contained 130 mM NaCl, 2.7 mM KCl, 1.5 mM KH 2 PO 4 , 1 mM CaCl 2 , 0.5 mM MgCl 2 , 10 mM HEPES-Na and 10 mM glucose, pH 7.3. A Cl À gradient was imposed using an apical solution with a lower NaCl concentration. The apical solution was similar to the basolateral solution, with half of the NaCl replaced with sodium gluconate, and CaCl 2 increased to 2 mM, to compensate for the calcium buffering caused by gluconate. During the experiments, the solutions in both of the chambers were continuously bubbled with air and the temperature was maintained at 37 1C. The hemi-chambers were connected to a DVC-1000 voltage clamp (World Precision Instruments, Sarasota, FL, USA) via Ag/AgCl electrodes and 1 M KCl agar bridges, for recording short-circuit currents. Transepithelial currents were digitized using a PowerLab 4/25 data acquisition system (AD Instruments, Chalgrove, Oxfordshire, UK), and stored on Macintosh computers for analysis.
Statistical analysis
Significant differences between experimental groups of data were established using two-tailed Student's t-tests.
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